Exelixis, Inc. (EXEL)
USD 35.74
(1.22%)
USD 35.74
(1.22%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.75 Billion USD | 13.17% |
| 2022 | 1.55 Billion USD | 12.38% |
| 2021 | 1.38 Billion USD | 45.29% |
| 2020 | 951.26 Million USD | 1.77% |
| 2019 | 934.67 Million USD | 12.96% |
| 2018 | 827.47 Million USD | 89.18% |
| 2017 | 437.41 Million USD | 136.56% |
| 2016 | 184.9 Million USD | 455.65% |
| 2015 | 33.27 Million USD | 44.26% |
| 2014 | 23.06 Million USD | -23.67% |
| 2013 | 30.22 Million USD | -36.31% |
| 2012 | 47.45 Million USD | -83.62% |
| 2011 | 289.63 Million USD | 56.52% |
| 2010 | 185.04 Million USD | 21.93% |
| 2009 | 151.75 Million USD | 28.76% |
| 2008 | 117.85 Million USD | 4.05% |
| 2007 | 113.26 Million USD | 15.76% |
| 2006 | 97.85 Million USD | 30.68% |
| 2005 | 74.87 Million USD | 43.77% |
| 2004 | 52.07 Million USD | 1.04% |
| 2003 | 51.54 Million USD | 16.29% |
| 2002 | 44.32 Million USD | 8.09% |
| 2001 | 41 Million USD | -5.42% |
| 2000 | 43.35 Million USD | 167.63% |
| 1999 | 16.2 Million USD | 613.03% |
| 1998 | 2.27 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 460.73 Million USD | -15.71% |
| 2024 Q1 | 403.97 Million USD | -11.78% |
| 2024 Q2 | 619.51 Million USD | 53.36% |
| 2023 Q3 | 453.14 Million USD | 0.22% |
| 2023 Q4 | 457.89 Million USD | 1.05% |
| 2023 Q1 | 394.47 Million USD | -3.31% |
| 2023 Q2 | 452.14 Million USD | 14.62% |
| 2023 FY | 1.75 Billion USD | 13.17% |
| 2022 Q1 | 342.77 Million USD | -21.78% |
| 2022 Q4 | 407.99 Million USD | 2.92% |
| 2022 Q3 | 396.43 Million USD | -2.34% |
| 2022 FY | 1.55 Billion USD | 12.38% |
| 2022 Q2 | 405.94 Million USD | 18.43% |
| 2021 Q4 | 438.22 Million USD | 38.44% |
| 2021 FY | 1.38 Billion USD | 45.29% |
| 2021 Q1 | 257.03 Million USD | -1.53% |
| 2021 Q2 | 370.29 Million USD | 44.06% |
| 2021 Q3 | 316.54 Million USD | -14.51% |
| 2020 Q2 | 250.25 Million USD | 14.99% |
| 2020 FY | 951.26 Million USD | 1.77% |
| 2020 Q3 | 222.36 Million USD | -11.14% |
| 2020 Q4 | 261.01 Million USD | 17.38% |
| 2020 Q1 | 217.62 Million USD | -5.29% |
| 2019 FY | 934.67 Million USD | 12.96% |
| 2019 Q2 | 232.73 Million USD | 11.9% |
| 2019 Q1 | 207.98 Million USD | -6.0% |
| 2019 Q4 | 229.79 Million USD | -13.01% |
| 2019 Q3 | 264.16 Million USD | 13.5% |
| 2018 Q2 | 180.11 Million USD | -12.87% |
| 2018 FY | 827.47 Million USD | 89.18% |
| 2018 Q1 | 206.7 Million USD | 78.38% |
| 2018 Q3 | 218.03 Million USD | 21.06% |
| 2018 Q4 | 221.25 Million USD | 1.47% |
| 2017 Q2 | 95.99 Million USD | 23.57% |
| 2017 Q3 | 147.85 Million USD | 54.02% |
| 2017 FY | 437.41 Million USD | 136.56% |
| 2017 Q1 | 77.68 Million USD | 2.58% |
| 2017 Q4 | 115.88 Million USD | -21.62% |
| 2016 Q2 | 34.69 Million USD | 135.33% |
| 2016 FY | 184.9 Million USD | 455.65% |
| 2016 Q3 | 59.73 Million USD | 72.2% |
| 2016 Q4 | 75.72 Million USD | 26.77% |
| 2016 Q1 | 14.74 Million USD | 65.36% |
| 2015 FY | 33.27 Million USD | 44.26% |
| 2015 Q4 | 8.91 Million USD | 5.7% |
| 2015 Q3 | 8.43 Million USD | 15.44% |
| 2015 Q2 | 7.3 Million USD | -15.26% |
| 2015 Q1 | 8.62 Million USD | 29.28% |
| 2014 Q2 | 6.08 Million USD | 32.4% |
| 2014 Q3 | 5.71 Million USD | -6.03% |
| 2014 Q1 | 4.59 Million USD | 12.54% |
| 2014 Q4 | 6.66 Million USD | 16.63% |
| 2014 FY | 23.06 Million USD | -23.67% |
| 2013 Q1 | 9.38 Million USD | 20.16% |
| 2013 FY | 30.22 Million USD | -36.31% |
| 2013 Q2 | 11.57 Million USD | 23.24% |
| 2013 Q4 | 4.08 Million USD | -21.1% |
| 2013 Q3 | 5.17 Million USD | -55.27% |
| 2012 Q3 | 13.31 Million USD | 70.4% |
| 2012 Q4 | 7.81 Million USD | -41.31% |
| 2012 Q2 | 7.81 Million USD | -57.79% |
| 2012 Q1 | 18.51 Million USD | -80.16% |
| 2012 FY | 47.45 Million USD | -83.62% |
| 2011 FY | 289.63 Million USD | 56.52% |
| 2011 Q1 | 35.89 Million USD | -11.98% |
| 2011 Q2 | 32.16 Million USD | -10.39% |
| 2011 Q3 | 128.27 Million USD | 298.83% |
| 2011 Q4 | 93.3 Million USD | -27.26% |
| 2010 Q2 | 47.59 Million USD | 12.79% |
| 2010 Q4 | 40.77 Million USD | -25.15% |
| 2010 FY | 185.04 Million USD | 21.93% |
| 2010 Q1 | 42.19 Million USD | -4.26% |
| 2010 Q3 | 54.47 Million USD | 14.45% |
| 2009 Q1 | 23.5 Million USD | -20.51% |
| 2009 Q4 | 44.07 Million USD | -15.25% |
| 2009 Q3 | 52.01 Million USD | 101.88% |
| 2009 Q2 | 25.76 Million USD | 9.61% |
| 2009 FY | 151.75 Million USD | 28.76% |
| 2008 Q3 | 29.93 Million USD | -1.58% |
| 2008 Q2 | 30.41 Million USD | 8.83% |
| 2008 FY | 117.85 Million USD | 4.05% |
| 2008 Q1 | 27.94 Million USD | -3.8% |
| 2008 Q4 | 29.57 Million USD | -1.21% |
| 2007 Q1 | 28.06 Million USD | -71.32% |
| 2007 Q2 | 29.18 Million USD | 4.0% |
| 2007 Q3 | 26.77 Million USD | -8.27% |
| 2007 FY | 113.26 Million USD | 15.76% |
| 2007 Q4 | 29.04 Million USD | 8.49% |
| 2006 FY | 97.85 Million USD | 30.68% |
| 2006 Q1 | 17.84 Million USD | -76.16% |
| 2006 Q2 | 27.24 Million USD | 52.63% |
| 2006 Q3 | 23.54 Million USD | -13.58% |
| 2006 Q4 | 97.85 Million USD | 315.68% |
| 2005 Q3 | 14.4 Million USD | -58.03% |
| 2005 FY | 74.87 Million USD | 43.77% |
| 2005 Q2 | 34.31 Million USD | 166.51% |
| 2005 Q1 | 12.87 Million USD | -75.28% |
| 2005 Q4 | 74.87 Million USD | 419.97% |
| 2004 Q4 | 52.07 Million USD | 311.29% |
| 2004 FY | 52.07 Million USD | 1.04% |
| 2004 Q1 | 11.89 Million USD | -13.61% |
| 2004 Q3 | 12.66 Million USD | 0.82% |
| 2004 Q2 | 12.55 Million USD | 5.61% |
| 2003 Q1 | 12.33 Million USD | -0.99% |
| 2003 Q2 | 13 Million USD | 5.47% |
| 2003 Q3 | 12.43 Million USD | -4.35% |
| 2003 FY | 51.54 Million USD | 16.29% |
| 2003 Q4 | 13.76 Million USD | 10.67% |
| 2002 Q3 | 10.43 Million USD | 5.39% |
| 2002 Q1 | 11.56 Million USD | -9.64% |
| 2002 Q2 | 9.89 Million USD | -14.39% |
| 2002 FY | 44.32 Million USD | 8.09% |
| 2002 Q4 | 12.45 Million USD | 19.4% |
| 2001 Q2 | 8.55 Million USD | -9.78% |
| 2001 Q3 | 11.92 Million USD | 39.49% |
| 2001 Q4 | 12.79 Million USD | 7.25% |
| 2001 FY | 41 Million USD | -5.42% |
| 2001 Q1 | 9.47 Million USD | -10.46% |
| 2000 FY | 43.35 Million USD | 167.63% |
| 2000 Q2 | 11.87 Million USD | 18.78% |
| 2000 Q3 | 10.89 Million USD | -8.24% |
| 2000 Q1 | 9.99 Million USD | 0.0% |
| 2000 Q4 | 10.58 Million USD | -2.86% |
| 1999 FY | 16.2 Million USD | 613.03% |
| 1998 FY | 2.27 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Agenus Inc. | 139.61 Million USD | -1158.934% |
| Immix Biopharma, Inc. | -5468.00 USD | 32144595.245% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 264807.982% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 2365.085% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 333622.011% |
| MiMedx Group, Inc. | 266.84 Million USD | -558.687% |
| Novavax, Inc. | 639.93 Million USD | -174.662% |
| Seer, Inc. | 7.02 Million USD | -24912.964% |
| Acelyrin, Inc. | -115 Thousand USD | 1528500.87% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -1199.382% |
| IO Biotech, Inc. | -756 Thousand USD | 232594.841% |
| Ardelyx, Inc. | 106.66 Million USD | -1547.895% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 1912.956% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 5739.374% |
| Fortress Biotech, Inc. | 57.85 Million USD | -2938.15% |
| Fortress Biotech, Inc. | 57.85 Million USD | -2938.15% |
| Geron Corporation | -123.5 Million USD | 1523.173% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -630.123% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -10503.01% |
| Incyte Corporation | 3.44 Billion USD | 48.915% |
| Innoviva, Inc. | 261.06 Million USD | -573.266% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 3195847.273% |
| ChromaDex Corporation | 50.78 Million USD | -3361.325% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -1367.739% |
| MEI Pharma, Inc. | 49.32 Million USD | -3463.284% |
| NextCure, Inc. | -3.68 Million USD | 47810.668% |
| Onconetix, Inc. | -1.12 Million USD | 156036.442% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 6167.595% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 1226651.804% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 1756.249% |
| Vaxcyte, Inc. | -75 Million USD | 2443.548% |
| Precigen, Inc. | 106 Thousand USD | -1658070.755% |
| Pharming Group N.V. | 220.1 Million USD | -698.559% |
| ContextLogic Inc. | 59 Million USD | -2879.086% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 757712.5% |
| Pyxis Oncology, Inc. | -2 Million USD | 87983.05% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -1501.192% |
| AlloVir, Inc. | -398 Thousand USD | 441723.367% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -5949.427% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 17487524.137% |
| Summit Therapeutics Inc. | -2.05 Million USD | 85839.561% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 14647275.0% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 307921.541% |
| Senti Biosciences, Inc. | -2.68 Million USD | 65611.032% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -1464617.5% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 36733.201% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -5934.059% |
| Psyence Biomedical Ltd. | -240.00 USD | 732358850.0% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 3977788.513% |
| Chimerix, Inc. | 324 Thousand USD | -542387.963% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 3066179.964% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 2143589.024% |
| CRISPR Therapeutics AG | 240.95 Million USD | -629.453% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -1588.451% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -341193.398% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -174098.315% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 47707.286% |
| Precision BioSciences, Inc. | 40.47 Million USD | -4242.906% |
| Dyadic International, Inc. | 922.95 Thousand USD | -190338.016% |
| Elevation Oncology, Inc. | -39 Thousand USD | 4506923.077% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -8245.572% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -1358.955% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | -15.797% |
| Aptorum Group Limited | -1.11 Million USD | 157781.88% |
| Bicycle Therapeutics plc | -129.52 Million USD | 1457.058% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 44687.509% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -22230.847% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 13258.265% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Alkermes plc | 1.37 Billion USD | -27.86% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -40047.579% |
| Jaguar Health, Inc. | 7.72 Million USD | -22655.839% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -354267.137% |
| AbCellera Biologics Inc. | 38.02 Million USD | -4522.383% |
| PureTech Health plc | -1.6 Million USD | 109748.222% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 340240.224% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 3977.906% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -219059.726% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -8058.092% |
| AnaptysBio, Inc. | 14.78 Million USD | -11791.354% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 7769.013% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 1483470.889% |
| Molecular Templates, Inc. | 50.39 Million USD | -3387.769% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -5881.083% |
| Vaxxinity, Inc. | -2.23 Million USD | 78777.753% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 357348.171% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 8094.092% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 3852.559% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 185277.955% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 35153320.0% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -43288.324% |
| ImmuCell Corporation | 4.39 Million USD | -39880.606% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 1005379.594% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -414442.689% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -9129.959% |
| Opthea Limited | 21.72 Thousand USD | -8092261.878% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 1068.899% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 1889.569% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 1890.553% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -288514.286% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -460.35% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -68185.198% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 3464154.001% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 24862.764% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 370488.688% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 16900686.538% |
| Soligenix, Inc. | 97.31 Thousand USD | -1806130.539% |
| Century Therapeutics, Inc. | -10.8 Million USD | 16361.088% |
| Kura Oncology, Inc. | -849 Thousand USD | 207127.208% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 2719.309% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 1195787.755% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -1674.716% |
| Autolus Therapeutics plc | -4.86 Million USD | 36213.848% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -4146.994% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 1046326.786% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -1755.58% |
| GRI Bio, Inc. | 10.84 Million USD | -16113.089% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -69099.633% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 20333.234% |
| IGM Biosciences, Inc. | -211.66 Million USD | 930.417% |
| INmune Bio, Inc. | 155 Thousand USD | -1133874.839% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -2737.729% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 116788.01% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 271154.076% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 6004270.937% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -437129.104% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 88159.168% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 561653.035% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -1760.727% |
| Verastem, Inc. | -62 Thousand USD | 2835037.097% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -72083.203% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 673533.333% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -57966.105% |
| Histogen Inc. | 3.76 Million USD | -46534.678% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -304954.679% |
| Surrozen, Inc. | -27.23 Million USD | 6554.87% |
| Organovo Holdings, Inc. | -5.38 Million USD | 32715.717% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 145978.511% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 6953.281% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -8665.515% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 88770857.576% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -28873.598% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 2618355.351% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -1035.506% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -1205428.807% |
| Apollomics, Inc. | 127 Thousand USD | -1383885.039% |
| Amarin Corporation plc | 165.54 Million USD | -961.768% |
| Mesoblast Limited | -9.81 Million USD | 18007.906% |
| Turnstone Biologics Corp. | 16.5 Million USD | -10548.619% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 1690.802% |
| Synaptogenix, Inc. | -6347.00 USD | 27692883.992% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 3446494.118% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -989.245% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Better Therapeutics, Inc. | -2.72 Million USD | 64506.779% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 1667.087% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -419.893% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 15407366.83% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 28177.652% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 158733.664% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -23918.321% |
| Insmed Incorporated | 239.63 Million USD | -633.474% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -49024.12% |
| OmniAb, Inc. | 14.66 Million USD | -11883.78% |
| Alector, Inc. | -95.05 Million USD | 1949.138% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -1299.178% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 4144.04% |
| Zai Lab Limited | 170.9 Million USD | -928.455% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -2046.709% |
| Aura Biosciences, Inc. | -1.29 Million USD | 135826.718% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -1351946.923% |
| Immunic, Inc. | -111 Thousand USD | 1583578.378% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -10986.546% |
| Veracyte, Inc. | 248.14 Million USD | -608.312% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 125.149% |
| FibroGen, Inc. | 128.9 Million USD | -1263.543% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 311642121.277% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 15165.384% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 48.283% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -451740.874% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -394.635% |
| TG Therapeutics, Inc. | 219.1 Million USD | -702.189% |
| Galecto, Inc. | -830 Thousand USD | 211866.386% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 127006.931% |
| Fortrea Holdings Inc. | 424 Million USD | -314.543% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 2139.831% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 310093.122% |
| XBiotech Inc. | -1.74 Million USD | 100883.314% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 158733.664% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 3882.275% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 2426.98% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -2294.536% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -10360.4% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -351.794% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 3640.317% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -437.921% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 15621.773% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -7088.504% |
| NexImmune, Inc. | -1.02 Million USD | 171583.806% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -32549177.778% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 24836.083% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 84.447% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 2630265.951% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 49597.634% |
| Ainos, Inc. | -253.73 Thousand USD | 692820.695% |
| Pluri Inc. | 322 Thousand USD | -545757.453% |
| Prothena Corporation plc | -129.2 Million USD | 1460.408% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -3385.767% |
| Celularity Inc. | 6.75 Million USD | -25920.148% |
| Rallybio Corporation | -150 Thousand USD | 1171874.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 5490.441% |
| MeiraGTx Holdings plc | 287 Thousand USD | -612325.436% |
| Omeros Corporation | -69.77 Million USD | 2618.897% |
| Humacyte, Inc. | -76.55 Million USD | 2396.095% |
| Immunocore Holdings plc | 248.39 Million USD | -607.619% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 11687.191% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -2717.577% |
| Blueprint Medicines Corporation | 236.58 Million USD | -642.933% |
| CalciMedica, Inc. | -58 Thousand USD | 3030550.0% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 123358.135% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 61902.426% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 5794.674% |
| Pulmatrix, Inc. | -8.22 Million USD | 21482.737% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 150327.436% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 440616.541% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 540.744% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -63225.785% |
| Cytokinetics, Incorporated | -322.59 Million USD | 644.854% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -203780.154% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 515543.109% |
| Vor Biopharma Inc. | -3.49 Million USD | 50433.935% |
| Roivant Sciences Ltd. | 109.23 Million USD | -1509.064% |
| Evogene Ltd. | 1.39 Million USD | -125536.955% |
| ProKidney Corp. | -3.16 Million USD | 55564.216% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 4102.689% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -25533.09% |
| CorMedix Inc. | -205.56 Thousand USD | 855151.517% |
| BioLineRx Ltd. | 1.1 Million USD | -158533.664% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 2334.192% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 5326345.455% |
| Atai Life Sciences N.V. | -5000.00 USD | 35153320.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 1442472.742% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 1830996.875% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 126641.469% |
| Sagimet Biosciences Inc. | 2 Million USD | -87783.05% |
| MediciNova, Inc. | 979.7 Thousand USD | -179307.168% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 2184.537% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 1858976.844% |
| GeoVax Labs, Inc. | -20.72 Million USD | 8582.606% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -618.777% |
| Biomea Fusion, Inc. | -4.2 Million USD | 41939.11% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -101.489% |
| Mereo BioPharma Group plc | 7.42 Million USD | -23569.014% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 567087.419% |
| Absci Corporation | -41.84 Million USD | 4300.007% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 35153320.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 2401.417% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 71520.601% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -722.355% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 186886.504% |
| Allakos Inc. | -6.14 Million USD | 28721.739% |
| Imunon, Inc. | -720 Thousand USD | 244217.888% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 2647.482% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -269.339% |
| BioAtla, Inc. | -103.73 Million USD | 1794.441% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 15407366.83% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 987550.0% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 823.856% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 565264.309% |
| XOMA Corporation | 3.86 Million USD | -45423.465% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 2607.899% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -11780.904% |
| aTyr Pharma, Inc. | -2.38 Million USD | 73703.894% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -14006.429% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 6061000.0% |
| Viridian Therapeutics, Inc. | -1 Million USD | 174471.131% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -13520469130.769% |
| Akari Therapeutics, Plc | -4000.00 USD | 43941625.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -175.975% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -902616.375% |
| UroGen Pharma Ltd. | 73.35 Million USD | -2296.201% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 6684.48% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -15139098.966% |
| Orgenesis Inc. | -5.72 Million USD | 30801.502% |
| Entera Bio Ltd. | -56 Thousand USD | 3138780.357% |
| GH Research PLC | -315 Thousand USD | 558087.619% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 930079.365% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 334892.571% |
| Xencor, Inc. | -85.26 Million USD | 2161.531% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 795504.499% |
| Replimune Group, Inc. | -2.65 Million USD | 66301.921% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 175649.121% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -888.316% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -902616.375% |
| Portage Biotech Inc. | -54 Thousand USD | 3255027.778% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 1858976.844% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 466323.077% |
| OncoCyte Corporation | 413 Thousand USD | -425483.777% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 39102680.645% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 791739289.189% |
| Purple Biotech Ltd. | -196 Thousand USD | 896865.816% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -19499.253% |
| scPharmaceuticals Inc. | 9.78 Million USD | -17868.319% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 16927.843% |
| HilleVax, Inc. | -2.15 Million USD | 81624.165% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 1812121.649% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 11714716.102% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 263222.904% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 7642104.348% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 23416347.455% |
| Savara Inc. | -44.26 Million USD | 4071.038% |
| Curis, Inc. | 9.81 Million USD | -17815.207% |
| Daré Bioscience, Inc. | 2.76 Million USD | -63364.417% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 1408617.646% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 101757.663% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 771003.947% |
| BeiGene, Ltd. | 2.07 Billion USD | 15.451% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 62965.66% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 539.785% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -3000.587% |
| Erasca, Inc. | -3.73 Million USD | 47197.026% |
| bluebird bio, Inc. | -4.03 Million USD | 43714.417% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 6228964.555% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 7.704% |
| DBV Technologies S.A. | 15.72 Million USD | -11075.362% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 6228964.555% |
| Moderna, Inc. | 2.15 Billion USD | 18.438% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 192194.098% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -21854.297% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 328021.828% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -1213.766% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 28349.132% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 4567.532% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 1681.654% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 49087.207% |
| MacroGenics, Inc. | 50.52 Million USD | -3378.657% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 28923.565% |
| Prime Medicine, Inc. | -147.9 Million USD | 1288.372% |
| Aditxt, Inc. | -111.66 Thousand USD | 1574218.753% |
| Adagene Inc. | 18.11 Million USD | -9604.673% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -360076.434% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -1153.663% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -1013.6% |
| SciSparc Ltd. | 2.19 Million USD | -79939.208% |
| Vericel Corporation | 135.57 Million USD | -1196.44% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 7016990.894% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 5673268.291% |
| Generation Bio Co. | -73.91 Million USD | 2478.078% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 402310.755% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -3118.04% |
| Invivyd, Inc. | -2.02 Million USD | 86769.675% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 684.249% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 1699341.091% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -1723.905% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -1688.276% |
| ADMA Biologics, Inc. | 88.21 Million USD | -1892.406% |
| Clene Inc. | 533 Thousand USD | -329667.542% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -7190.421% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 183763.636% |
| GeoVax Labs, Inc. | -20.72 Million USD | 8582.606% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -88313.531% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 904637.454% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -3429.085% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 24883.714% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 210346.531% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -2007.128% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -2403966.364% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -3206.236% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 1114.886% |
| Trevena, Inc. | 1.45 Million USD | -120701.443% |
| Surrozen, Inc. | -27.23 Million USD | 6554.87% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 498020.963% |
| Cingulate Inc. | -582.91 Thousand USD | 301628.002% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 5669974.194% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 9022.59% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 23218871.466% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 199607.491% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -158.211% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 178000.911% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 3119728.341% |
| Kronos Bio, Inc. | 1.37 Million USD | -128009.402% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 3375.185% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 602038.699% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 360044.831% |
| ImmunityBio, Inc. | -17.89 Million USD | 9924.824% |
| Korro Bio, Inc. | -3.63 Million USD | 48520.413% |
| Kineta, Inc. | 5.43 Million USD | -32251.574% |
| BioVie Inc. | -229.37 Thousand USD | 766376.043% |
| Codexis, Inc. | 57.33 Million USD | -2965.652% |
| Celularity Inc. | 6.75 Million USD | -25920.148% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -43699.178% |
| Celcuity Inc. | -142.77 Thousand USD | 1231196.433% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -3474224.965% |
| Cibus, Inc. | 1.42 Million USD | -123504.852% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 470062.834% |
| IN8bio, Inc. | -2.5 Million USD | 70378.329% |
| Kodiak Sciences Inc. | -25.94 Million USD | 6874.043% |
| Annexon, Inc. | -3.26 Million USD | 53900.459% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 86091.243% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 4311.278% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -274534.531% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -125.771% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -916.253% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 92608.474% |
| Arcellx, Inc. | 108.27 Million USD | -1523.27% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 5530.075% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -2119.157% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 8409.668% |
| Moolec Science SA | -143.3 Thousand USD | 1226617.567% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 4253.46% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -53373.106% |
| Royalty Pharma plc | 1.79 Billion USD | 2.02% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 2607.72% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 48661810.963% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -759506.467% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 1677.594% |
| Humacyte, Inc. | -76.55 Million USD | 2396.095% |
| 89bio, Inc. | -273 Thousand USD | 643931.868% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 139929.833% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 207371.344% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 1429092.683% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -156974.263% |
| Notable Labs, Ltd. | 113 Thousand USD | -1555352.212% |
| Liquidia Corporation | 14.6 Million USD | -11938.774% |
| Mustang Bio, Inc. | -2.22 Million USD | 79096.0% |
| Immunovant, Inc. | -231 Thousand USD | 760992.208% |
| Quantum-Si incorporated | 488 Thousand USD | -360076.434% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 3263.594% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 5858970.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -94296.402% |
| Acasti Pharma Inc. | -11 Thousand USD | 15978836.364% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 859100.474% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 271154.076% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 1149.275% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -154817.326% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 461428.346% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 89868.182% |
| PepGen Inc. | -1.18 Million USD | 148551.098% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 1384085.039% |
| United Therapeutics Corporation | 2.07 Billion USD | 15.089% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 7776.381% |
| Solid Biosciences Inc. | -76.56 Million USD | 2395.705% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 2128456.926% |
| Immuneering Corporation | -764.13 Thousand USD | 230118.792% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -2652412.677% |
| Belite Bio, Inc | -399 Thousand USD | 440616.541% |
| XOMA Corporation | 3.86 Million USD | -45423.465% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 8872.514% |
| Bionomics Limited | -434.44 Thousand USD | 404672.458% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 163755.587% |
| uniQure N.V. | 2.21 Million USD | -79252.641% |
| Cassava Sciences, Inc. | -89.42 Million USD | 2065.558% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 2009.069% |
| Forte Biosciences, Inc. | -9000.00 USD | 19529666.667% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 210598.323% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 402310.755% |
| Altimmune, Inc. | -65.37 Million USD | 2788.665% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -385.501% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 163755.587% |
| Compugen Ltd. | 31.45 Million USD | -5487.859% |
| Peak Bio, Inc. | 367.76 Thousand USD | -477825.274% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -7069.444% |
| Benitec Biopharma Inc. | 108 Thousand USD | -1627363.889% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 2253511.538% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 146206.484% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 96568.771% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 1477126.05% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 146206.484% |
| Instil Bio, Inc. | -4.75 Million USD | 37056.707% |
| argenx SE | 1.1 Billion USD | -58.565% |
| Immunome, Inc. | -8.9 Million USD | 19833.479% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 93097.937% |
| Verona Pharma plc | -679.62 Thousand USD | 258722.562% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 1004477.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | 73796.478% |
| CervoMed Inc. | -1.29 Million USD | 135970.773% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 73122.892% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 36894.243% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -71031.566% |
| Moolec Science SA | -143.3 Thousand USD | 1226617.567% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 430867.591% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 65892.348% |
| Design Therapeutics, Inc. | -537 Thousand USD | 327411.173% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 411730.211% |
| NeurAxis, Inc. | 2.15 Million USD | -81397.554% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -81804.054% |
| Lumos Pharma, Inc. | 2 Million USD | -87476.532% |
| Achilles Therapeutics plc | -4.73 Million USD | 37249.901% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 1004477.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 1663370.405% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -5451.896% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -203780.154% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 170415.988% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 3958.92% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -4087483.721% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 213927.372% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 13358216.735% |
| Palisade Bio, Inc. | 246 Thousand USD | -714396.341% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 5326345.455% |
| Beam Therapeutics Inc. | -59.67 Million USD | 3045.537% |
| Neurogene Inc. | -3.26 Million USD | 53982.925% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -1161.464% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -4294.153% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 591905.051% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 43746.507% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 18474.043% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -12383.388% |
| Athira Pharma, Inc. | -969 Thousand USD | 181489.164% |
| Vaccinex, Inc. | -16 Million USD | 11082.636% |
| HCW Biologics Inc. | -574.82 Thousand USD | 305873.767% |
| XOMA Corporation | 3.86 Million USD | -45423.465% |
| Nektar Therapeutics | 53.47 Million USD | -3186.699% |
| Arvinas, Inc. | 71.8 Million USD | -2347.996% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 2205.966% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 2899.938% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 545957.453% |
| Rezolute, Inc. | -36 Thousand USD | 4882491.667% |
| Clene Inc. | 533 Thousand USD | -329667.542% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 136889585.981% |
| BeyondSpring Inc. | 1.75 Million USD | -100280.411% |
| Synlogic, Inc. | -1.92 Million USD | 91454.522% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 4750535.135% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 27858.386% |
| Peak Bio, Inc. | 367.76 Thousand USD | -477825.274% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 9368.897% |
| Krystal Biotech, Inc. | 47.6 Million USD | -3592.177% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -1145.764% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -34878.328% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 67983.829% |
| MannKind Corporation | 136.19 Million USD | -1190.585% |
| Ikena Oncology, Inc. | -50.49 Million USD | 3581.068% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -1515.289% |
| Gossamer Bio, Inc. | -4.38 Million USD | 40183.489% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 697584.524% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 35153320.0% |
| Legend Biotech Corporation | 140.92 Million USD | -1147.196% |
| Mural Oncology plc | -2.56 Million USD | 68571.406% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 319094.737% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 1757761.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -8369.023% |
| REGENXBIO Inc. | 53.02 Million USD | -3214.528% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 32910.835% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 913763.938% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 101581.582% |
| Vaxart, Inc. | -60.76 Million USD | 2992.65% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 668971.68% |
| Cellectis S.A. | 18 Thousand USD | -9764683.333% |
| Longeveron Inc. | 221 Thousand USD | -795221.719% |
| Repare Therapeutics Inc. | -80.07 Million USD | 2295.155% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -60.812% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 135931.607% |
| Revolution Medicines, Inc. | -399.66 Million USD | 539.785% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 5021988.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -3586963.265% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 79.579% |
| Denali Therapeutics Inc. | -93.34 Million USD | 1982.973% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 7016990.894% |
| Veru Inc. | 7.56 Million USD | -23131.268% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 1164113.907% |
| Cingulate Inc. | -582.91 Thousand USD | 301628.002% |
| Passage Bio, Inc. | -3.72 Million USD | 47336.254% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 14593764.895% |
| Exicure, Inc. | -1.42 Million USD | 123617.99% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 459019.321% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -64926.304% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 342941.176% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -2480.015% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 1174952.113% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 3068.721% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -449429.668% |
| OmniAb, Inc. | 14.66 Million USD | -11883.78% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -8691.382% |
| Lipocine Inc. | -2.85 Million USD | 61754.62% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 95469.56% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 30909.132% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 116788.01% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -2233.715% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 2704193.846% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -1985.106% |
| Ocugen, Inc. | -33.53 Million USD | 5340.961% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 55687.002% |
| Q32 Bio Inc. | 578 Thousand USD | -303993.599% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 663368.302% |
| Alumis Inc. Common Stock | -1.28 Million USD | 136989.486% |
| Equillium, Inc. | 35.95 Million USD | -4788.094% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 103067.838% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -350955.467% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 42517298.839% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 678733.591% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -415705.797% |
| Dominari Holdings Inc. | 2.03 Million USD | -86102.109% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 958104.807% |
| vTv Therapeutics Inc. | -13.59 Million USD | 13028.731% |
| Bio-Techne Corporation | 773.07 Million USD | -127.36% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -10048.744% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -281.448% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 150455.945% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 7429.696% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -14926.597% |
| Nkarta, Inc. | -5.86 Million USD | 30048.219% |
| BioCardia, Inc. | -7.24 Million USD | 24346.944% |
| Iterum Therapeutics plc | -1.75 Million USD | 100537.771% |